Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene

被引:0
|
作者
Hiroaki Itamochi
Misaki Kato
Mayumi Nishimura
Nao Oumi
Tetsuro Oishi
Muneaki Shimada
Shinya Sato
Jun Naniwa
Seiya Sato
Michiko Nonaka
Akiko Kudoh
Naoki Terakawa
Junzo Kigawa
Tasuku Harada
机构
[1] Tottori University School of Medicine,Department of Obstetrics and Gynecology
[2] Tottori University Hospital Cancer Center,undefined
来源
Human Cell | 2013年 / 26卷
关键词
Ovarian clear cell adenocarcinoma; Establishment; mutation; Chemosensitivity; Molecular targeted therapy;
D O I
暂无
中图分类号
学科分类号
摘要
A new cell line of human ovarian clear cell adenocarcinoma (CCC), TU-OC-1, was established and characterized. The cells showed a polygonal-shaped morphology and grew in monolayers without contact inhibition and were arranged like a jigsaw puzzle. The chromosome numbers ranged from 64 to 90. A low rate of proliferation was observed, similar to other CCC cell lines tested (OVTOKO, RMG-I, and OVAS), and the doubling time was 38.4 h. The respective IC50 values of cisplatin and paclitaxel were 12.2 μM and 58.3 nM. Mutational analysis revealed that TU-OC-1 cells harbored a PIK3CA mutation at codon 542 (E542K) in exon 9, which is a mutation hot spot on this gene. We observed that phosphorylated Akt protein was overexpressed in TU-OC-1 cells by western blot analysis. Heterotransplantation to nude mice produced tumors that reflected the original. This cell line may be useful to study the chemoresistant mechanisms of CCC and contribute to novel treatment strategies.
引用
收藏
页码:121 / 127
页数:6
相关论文
共 50 条
  • [21] PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma
    Sohei Yamamoto
    Hitoshi Tsuda
    Masashi Takano
    Seiichi Tamai
    Osamu Matsubara
    Virchows Archiv, 2012, 460 : 77 - 87
  • [22] PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma
    Zhang, Lina
    Shi, Lei
    Zhao, Xiaoting
    Wang, Yue
    Yue, Wentao
    ONCOTARGETS AND THERAPY, 2013, 6 : 497 - 502
  • [23] An oncogenic, somatic mutation of PIK3CA identified in 2 primary malignancies: clear cell renal cell carcinoma and prostate adenocarcinoma in the same patient
    Marek-Bukowiec, Karolina
    Ratajczyk, Krzysztof
    Rogala, Joanna
    Kosinski, Mariusz
    Kowal, Pawel
    Witkiewicz, Wojciech
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (01): : 93 - 95
  • [24] Mutational Status of KRAS, BRAF, NRAS and PIK3CA in Primary Clear Cell Ovarian Carcinoma
    Zannoni, Gian Franco
    Chiarello, Gaia
    Petrillo, Marco
    Improta, Giuseppina
    Rossi, Esther D.
    Fadda, Guido
    Fraggetta, Filippo
    MODERN PATHOLOGY, 2015, 28 : 316A - 317A
  • [25] PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma
    Abe, Azusa
    Minaguchi, Takeo
    Ochi, Hiroyuki
    Onuki, Mamiko
    Okada, Satoshi
    Matsumoto, Koji
    Satoh, Toyomi
    Oki, Akinori
    Yoshikawa, Hiroyuki
    HUMAN PATHOLOGY, 2013, 44 (02) : 199 - 207
  • [26] Mutational Status of KRAS, BRAF, NRAS and PIK3CA in Primary Clear Cell Ovarian Carcinoma
    Zannoni, Gian Franco
    Chiarello, Gaia
    Petrillo, Marco
    Improta, Giuseppina
    Rossi, Esther D.
    Fadda, Guido
    Fraggetta, Filippo
    LABORATORY INVESTIGATION, 2015, 95 : 316A - 317A
  • [27] Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma
    Al-Amri, Ali M.
    Vatte, Chittibabu
    Cyrus, Cyril
    Chathoth, Shahanas
    Hashim, Tariq Mohammad
    Mohamed, Yehia S.
    Al Ali, Rudaynah
    Alsaid, Abir
    Al Ali, Amein
    CANCER BIOMARKERS, 2016, 16 (03) : 377 - 383
  • [28] Establishment and characterization of the RMG-V cell line from human ovarian clear cell adenocarcinoma.
    Aoki D.
    Suzuki N.
    Susumu N.
    Noda T.
    Suzuki A.
    Tamada Y.
    Higashiguchi A.
    Oie S.
    Nozawa S.
    Human Cell, 2005, 18 (3) : 143 - 146
  • [29] Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma
    Su, Yu-Fa
    Tsai, Eing-Mei
    Chen, Chih-Chieh
    Wu, Chun-Chieh
    Er, Tze-Kiong
    CLINICA CHIMICA ACTA, 2019, 494 : 1 - 7
  • [30] Establishment and genomic characterization of gingivobuccal carcinoma cell lines with smokeless tobacco associated genetic alterations and oncogenic PIK3CA mutation
    Pansare, Kshama
    Gardi, Nilesh
    Kamat, Sayee
    Dange, Prerana
    Previn, Rahul
    Gera, Poonam
    Kowtal, Pradnya
    Amin, Kishore
    Sarin, Rajiv
    SCIENTIFIC REPORTS, 2019, 9 (1)